Clinical feasibility of accelerated whole liver water T<sub>1</sub> mapping with T<sub>2</sub>*-compensation. [PDF]
Huaroc Moquillaza E +7 more
europepmc +1 more source
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Beyond Species Richness: A Statistically Rigorous Comparison of eDNA and Conventional Fish Sampling Methods. [PDF]
Bonk EA +3 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Impact of linear programming-based optimization of pediatric hospital location and quantity on patient travel time in Germany. [PDF]
Lesniowski D, Terliesner N.
europepmc +1 more source
An Application of the Weighted Mean Value Method to Fredholm integral equations with Toeplitz plus Hankel kernels [PDF]
Ahmet Altürk, Serpil Şahin
openalex +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Pareto-Front Optimization of Variance-Added Expected Loss with Interrelated Qualities. [PDF]
Kim S, Lee K.
europepmc +1 more source
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte +13 more
wiley +1 more source

